Weight loss injections for men: what the evidence actually says

You've read about these injections everywhere — here's what's actually true for men

Perhaps a colleague mentioned Mounjaro, or you spotted Wegovy in a news article about celebrity weight loss. Either way, you're probably wondering whether weight loss injections are genuinely suited to men or whether they're largely marketed at women. The short answer: the UK clinical trials enrolled men and women together, the licensing criteria make no sex distinction, and the biological mechanisms behind both medicines don't care about your sex at all.

What does differ, on average, is where men carry excess weight. Visceral fat (the type stored around the organs, deeper in the abdomen) is more common in men with obesity, and it is strongly linked to cardiovascular risk, insulin resistance and type 2 diabetes. Both tirzepatide and semaglutide reduce appetite and slow gastric emptying through gut-hormone pathways, and this works on stored fat as part of overall weight loss regardless of where that fat sits.

Men who are curious about which injection has been compared to which, and at what average results, will find a detailed breakdown on our guide to weight loss injections in the UK. The key point here is that in SURMOUNT-1, the main phase-3 trial for tirzepatide published in the New England Journal of Medicine, participants using the highest dose lost an average of around 20–21% of body weight over 72 weeks. The STEP 1 trial for semaglutide 2.4mg reported around 15% average weight loss over 68 weeks. Both figures come from mixed-sex participant groups.

One thing a prescriber will look at for any man starting these medicines is blood pressure, cholesterol and blood sugar, not to disqualify you, but because those readings help establish whether a weight-related condition is present and therefore what the most appropriate dose pathway looks like.

Eligibility for men: the BMI thresholds that actually apply

A question our prescribers hear most weeks is whether men need a higher BMI than women to qualify. They do not. The UK licensing criteria for both tirzepatide and semaglutide set the threshold at a BMI of 30 or above, or 27 or above if you have at least one weight-related health condition. Those conditions include hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes, conditions that are, in practice, more prevalent among men with excess weight.

Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance, reflecting the fact that health risks associated with excess weight can occur at lower BMIs in South Asian, Chinese, Middle Eastern, Black African or African-Caribbean populations. If you're unsure where you sit, the NHS BMI calculator is a reasonable starting point, though a prescriber assesses the full picture rather than BMI in isolation.

Private access does not require a GP referral or a waiting list. If you meet the clinical criteria (and a prescriber confirms this after reviewing your consultation) you can start treatment promptly. Our eligibility guide covers the full criteria in detail, including what happens if your BMI is close to a threshold.

NHS access follows a stricter phased rollout. As of June 2025, NHS tirzepatide is available to adults with a BMI of 40 or above who have four or more specific weight-related conditions. A second cohort (BMI 35–39.9 with four or more conditions) opened in June 2026. Waiting lists through specialist services also exist for Wegovy. For men who don't meet NHS criteria or prefer not to wait, understanding private treatment costs is a sensible next step.

Practical side: injections, needles and what men actually ask about

Both Mounjaro and Wegovy come as pre-filled pens, injected once a week into the abdomen, thigh or upper arm. The needles are fine-gauge, and most people find the injection itself takes seconds. Treatment starts at the lowest dose to let your body adjust, then titrates upward every four weeks at the prescriber's direction.

Storage is straightforward: both pens are kept in the fridge between doses. If you're travelling, there is a limited window for room-temperature storage, the exact duration is in the Patient Information Leaflet that comes with your pen, and this is the authoritative source, not anything you've read online. For safe disposal, a sharps container is the correct method; standard household bins are not appropriate for used pens or needles.

Side effects in men follow the same pattern seen across both sexes: nausea, loose stools, indigestion and reduced appetite are the most frequently reported, particularly in the early weeks. Fatigue and mild headache can occur. Severe, persistent stomach pain that radiates to the back should be taken seriously and assessed promptly by a clinician, the MHRA highlighted acute pancreatitis as a known, though infrequent, side effect in a Drug Safety Update issued in January 2026. Any suspected side effects can also be reported directly through the Yellow Card scheme.

If you want to compare how the two injections differ in terms of mechanism, schedule and average results, the full weight loss injection overview sets that out side by side. For men specifically researching tirzepatide, the Mounjaro injection page covers the dual-agonist mechanism and dosing schedule in plain terms.

What makes a safe online prescription service

Fake weight loss pens are a serious issue. The MHRA has seized approximately 20 million doses of illegally traded weight loss medicines with an estimated street value of around £45 million, and the first illicit UK manufacturing site producing counterfeit tirzepatide pens was raided in 2025. Some fake pens have contained insulin rather than the labelled medicine. The risk is not theoretical.

The reliable check is the GPhC register. Any online pharmacy operating legally in the UK must be registered, you can verify a pharmacy's registration number directly at the GPhC register. Sellers offering these medicines without a prescription, through social media, or at prices far below the market range are red flags. For context on what legitimate private treatment costs and what those prices include, the weight loss injection pricing page explains the market honestly.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it arrives. Your ID and weight are verified before treatment is issued. Orders placed before 12pm on a working day are dispatched the same day in plain packaging via tracked DPD delivery, arriving the next working day. If you'd like to check your eligibility, the process starts with a free consultation.